|
|
||||||||
B as Potential Targets1




* Department of Microbiology and Immunology, and National Research Lab of Dendritic Cell Differentiation & Regulation and Medical Research Institute, and
Department of Obstetrics and Gynecology, Pusan National University College of Medicine, Pusan, South Korea; and
Research Institute of Oriental Medicine & Clinical Research Center of Oriental Medicine, Dongeui University College of Oriental Medicine, Busan, South Korea
Curcumin has been shown to exhibit anti-inflammatory, antimutagenic, and anticarcinogenic activities. However, the effect of curcumin on the maturation and immunostimulatory function of dendritic cells (DC) largely remains unknown. In this study, we examined whether curcumin can influence surface molecule expression, cytokine production, and their underlying signaling pathways in murine bone marrow-derived DC. DC were derived from murine bone marrow cells and used as immature or LPS-stimulated mature cells. The DC were tested for surface molecule expression, cytokine production, dextran uptake, the capacity to induce T cell differentiation, and their underlying signaling pathways. Curcumin significantly suppressed CD80, CD86, and MHC class II expression, but not MHC class I expression, in the DC. The DC also exhibited impaired IL-12 expression and proinflammatory cytokine production (IL-1
, IL-6, and TNF-
). The curcumin-treated DC were highly efficient at Ag capture, via mannose receptor-mediated endocytosis. Curcumin inhibited LPS-induced MAPK activation and the translocation of NF-
B p65. In addition, the curcumin-treated DC showed an impaired induction of Th1 responses and a normal cell-mediated immune response. These novel findings provide new insight into the immunopharmacological role of curcumin in impacting on the DC. These novel findings open perspectives for the understanding of the immunopharmacological role of curcumin and therapeutic adjuvants for DC-related acute and chronic diseases.
This article has been cited by other articles:
![]() |
C. Capini, M. Jaturanpinyo, H.-I Chang, S. Mutalik, A. McNally, S. Street, R. Steptoe, B. O'Sullivan, N. Davies, and R. Thomas Antigen-Specific Suppression of Inflammatory Arthritis Using Liposomes J. Immunol., March 15, 2009; 182(6): 3556 - 3565. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-I. Jeong, S. W. Kim, I. D. Jung, J. S. Lee, J. H. Chang, C.-M. Lee, S. H. Chun, M.-S. Yoon, G. T. Kim, S. W. Ryu, et al. Curcumin Suppresses the Induction of Indoleamine 2,3-Dioxygenase by Blocking the Janus-activated Kinase-Protein Kinase C{delta}-STAT1 Signaling Pathway in Interferon-{gamma}-stimulated Murine Dendritic Cells J. Biol. Chem., February 6, 2009; 284(6): 3700 - 3708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Larmonier, J. K. Uno, K.-M. Lee, T. Karrasch, D. Laubitz, R. Thurston, M. T. Midura-Kiela, F. K. Ghishan, R. B. Sartor, C. Jobin, et al. Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G1079 - G1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Si, Y. Wang, J. Wong, J. Zhang, B. M. McManus, and H. Luo Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication J. Virol., April 1, 2007; 81(7): 3142 - 3150. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Chen, H.-T. Kuo, C.-Y. Chai, J.-L. Ou, and R.-C. Yang Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia Innate Immunity, February 1, 2007; 13(1): 15 - 23. [Abstract] [PDF] |
||||
![]() |
S. Bhattacharyya, D. Mandal, G. S. Sen, S. Pal, S. Banerjee, L. Lahiry, J. H. Finke, C. S. Tannenbaum, T. Das, and G. Sa Tumor-Induced Oxidative Stress Perturbs Nuclear Factor-{kappa}B Activity-Augmenting Tumor Necrosis Factor-{alpha}-Mediated T-Cell Death: Protection by Curcumin Cancer Res., January 1, 2007; 67(1): 362 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: The Ultimate Antagonist (I). Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |